Cargando…
Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
BACKGROUND: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...
Autores principales: | Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Leonardi, Francesca, Londei, Davide, Padovan, Marta, Caccese, Mario, Marchione, Giulia, Bini, Silvia, Zagonel, Vittorina, Frizziero, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278095/ https://www.ncbi.nlm.nih.gov/pubmed/32550861 http://dx.doi.org/10.1177/1758835920907543 |
Ejemplares similares
-
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
por: Parrozzani, Raffaele, et al.
Publicado: (2020) -
In vivo intraocular biomarkers: Changes of aqueous humor cytokines and chemokines in patients affected by uveal melanoma
por: Midena, Edoardo, et al.
Publicado: (2020) -
Small Fibre Peripheral Alterations Following COVID-19 Detected by Corneal Confocal Microscopy
por: Midena, Edoardo, et al.
Publicado: (2022) -
Uveal Melanoma Biopsy: A Review
por: Frizziero, Luisa, et al.
Publicado: (2019) -
Chorioretinal Side Effects of Therapeutic Ocular Irradiation: A Multimodal Imaging Approach
por: Midena, Giulia, et al.
Publicado: (2020)